immunology

Chimeric antigen receptor engineering is now possible for immune cells other than T cells, including macrophages and invariant natural killer T cells.

By removing immunosuppressive factors from the blood, researchers hope to give the immune system a fighting chance against advanced tumors.

A clear-eyed view of illness emerges from Alzheimer's disease.

People with COVID-19 sometimes lose their sense of smell. But a clinical researcher has a possible solution: the patient’s own blood.

Researchers face more obstacles studying the lung microbiome than the gut microbiome. One big hurdle is collecting lung samples. In a new study, researchers used an invasive technique to collect fluid from children’s lungs and discovered how the lung’s microbial makeup affects stem cell transplant outcomes.

LIVE JUNE 23rd, 2022 at 2:30 PM
Uncover genomic and epigenomic variations within a group of cells using single cell sequencing.

LIVE May 12th, 2022 at 2:30 PM
Discover the most current cell therapy research and the challenges of translating them into the clinic.

The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.

COVID-19 has gotten a little better at infecting cells and dodging antibodies with each set of mutations in new variants. Omicron is the best at dodging antibodies, but its modified structure sacrificed virulence for antibody resistance.

LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.